thiouracil 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
uracil derivatives used as thyroid antagonists 2640 141-90-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • thiouracil
  • nobilen
  • 2-mercapto-4-hydroxypyrimidine
  • 4-hydroxy-2-mercaptopyrimidine
  • antagothyroil
Occurs in seeds of Brassica and Crucifera species. Thiouracil has been used as antithyroid, coronary vasodilator, and in congestive heart failure although its use has been largely supplanted by other drugs. It is known to cause blood dyscrasias and suspected of terato- and carcinogenesis.
  • Molecular weight: 128.15
  • Formula: C4H4N2OS
  • CLOGP: -0.59
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 2
  • TPSA: 41.13
  • ALOGS: -1.58
  • ROTB: 0

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,ACVRL1,ALK,AURKA,AURKB,AURKC,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK5,CDK9,CHEK1,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,IRAK1,ITK,JAK1,JAK2,KIT,MAP2K6,MAP3K1,MAP3K10,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAPK1,MAPK10,MAPK12,MAPK7,MAPK9,MARK4,MET,MTOR,NTRK1,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CD,PIK3CG,PIM1,PIM2,PIM3,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ULK2 74
kinase-selectivity-class ACVR2A,ACVR2B,AXL,BRAF,CAMK2D,CDK9,DDR1,DYRK1B,EPHB4,ERBB2,GRK2,GRK3,IKBKB,IRAK1,MAP2K3,MAP3K14,MAP3K21,MAPK7,MARK4,PIK3CB,PIK3CD,PLK1,PLK2,PLK3,PRKDC,SIK2,STK33,TEK,ULK1 29
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D002317 Cardiovascular Agents
MeSH PA D006727 Hormone Antagonists
MeSH PA D013956 Antithyroid Agents
MeSH PA D014665 Vasodilator Agents
CHEBI has role CHEBI:25212 metabolite
CHEBI has role CHEBI:50671 antithyroid drug

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Thyrotoxic crisis indication 29028009 DOID:12837
Hyperthyroidism indication 34486009 DOID:7998
Necrotizing vasculitis contraindication 11791001
Hyperbilirubinemia contraindication 14783006 DOID:2741
Agranulocytosis contraindication 17182001 DOID:12987
Hypothyroidism contraindication 40930008 DOID:1459
Interstitial pneumonia contraindication 64667001
Leukopenia contraindication 84828003 DOID:615
Pancytopenia contraindication 127034005 DOID:12450
Liver function tests abnormal contraindication 166603001
Drug-induced hepatitis contraindication 235876009
Pregnancy, function contraindication 289908002
Thrombocytopenic disorder contraindication 302215000 DOID:1588
Bone marrow depression contraindication 307762000




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.02 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C0039957 UMLSCUI
CHEMBL345768 ChEMBL_ID
1269845 PUBCHEM_CID
D013889 MESH_DESCRIPTOR_UI
59X161SCYL UNII
55358003 SNOMEDCT_US
TUL PDB_CHEM_ID
59X161SCYL INXIGHT DRUGS

Pharmaceutical products:

None